Loading…
Veerhealth Care (BSE 511523)₹51.42+4.68%Pharmaceuticals
Veerhealth Care is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 177.3 against a peer median of 23.4, and ROCE of 7.2% against a peer median of 7.2%, and latest-quarter sales growth of 198.0% against a peer median of 36.0%. By market cap it is #6 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Godavari Drugs | 122 | 24.2 | 7.0 | 6.4 | 1.00 | 0.0 | 106 | 4 | 30.1 | 45.5 | vs BSE 511523 |
| Alpa Laboratories | 119 | 28.6 | 9.1 | 8.3 | 0.02 | 0.0 | 106 | 15 | 25.3 | −91.6 | vs BSE 511523 |
| Makers Laboratories | 111 | 14.9 | 9.0 | 3.2 | 0.05 | 0.0 | 141 | 8 | 41.0 | 1,064.4 | vs BSE 511523 |
| Tyche Industries | 109 | 15.9 | 6.8 | 5.0 | 0.00 | 2.8 | 54 | 7 | 31.0 | 22.1 | vs BSE 511523 |
| Pharmaids Pharmaceuticals | 106 | — | −18.4 | −26.5 | 0.49 | 0.0 | 28 | −12 | −38.2 | — | vs BSE 511523 |
| Veerhealth Care | 103 | 177.3 | 7.2 | 3.0 | 0.20 | 0.0 | 33 | 1 | 198.0 | — | — |
| Concord Drugs | 96 | 44.3 | 5.5 | 2.6 | 0.28 | 0.0 | 79 | 1 | 53.9 | 900.0 | vs BSE 511523 |
| Cian Healthcare | 94 | — | −16.1 | −49.2 | 3.38 | 0.0 | 28 | −23 | 41.6 | — | vs BSE 511523 |
| Vaishali Pharma | 91 | 23.4 | 7.9 | 6.0 | 0.28 | 0.0 | 109 | 4 | — | — | vs BSE 511523 |
| Mercury Laboratories | 88 | 21.2 | 12.1 | 9.1 | 0.14 | 0.5 | 76 | 5 | −12.0 | −69.8 | vs BSE 511523 |
| Amwill Health Care | 87 | 7.6 | 21.1 | 15.4 | 0.00 | 1.2 | 43 | 11 | 41.1 | 100.0 | vs BSE 511523 |
| Peer median | 103 | 23.4 | 7.2 | 5.0 | 0.20 | 0.0 | 76 | 4 | 36.0 | 45.5 |
Listed companies closest to Veerhealth Care in Pharmaceuticals include Godavari Drugs, Alpa Laboratories, Makers Laboratories, Tyche Industries, Pharmaids Pharmaceuticals, Concord Drugs, Cian Healthcare, Vaishali Pharma.
Godavari Drugs, with a market cap of ₹122 Cr.
Veerhealth Care trades at a P/E of 177.3; the median of its peer set is 23.4. A P/E above or below the median is a description, not a judgement on value.
Veerhealth Care's return on capital employed is 7.2%, above the peer median of 7.2%.